Asciminib Demonstrates Superior Efficacy and Safety in Newly Diagnosed Chronic Myeloid Leukemia in the ASC4FIRST Trial. Cortes JE, Hughes TP, Wang J, Kim DW, et al. Blood 2025 Dec 15:blood.2025029210. doi: 10.1182/blood.2025029210.

Read + Share

Amedeo Smart

Independent Medical Education